z-logo
open-access-imgOpen Access
Is phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway therapeutic target for esophageal adenocarcinoma
Author(s) -
Kazuto Harada,
Shumei Song,
Hideo Baba,
Jaffer A. Ajani
Publication year - 2017
Publication title -
shanghai chest
Language(s) - English
Resource type - Journals
ISSN - 2521-3768
DOI - 10.21037/shc.2017.10.07
Subject(s) - pi3k/akt/mtor pathway , protein kinase b , phosphatidylinositol , cancer research , esophageal adenocarcinoma , kinase , adenocarcinoma , signal transduction , medicine , microbiology and biotechnology , biology , cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom